Cargando…

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer

Mostrar otras versiones (1)

BACKGROUND: A patient's medical history and familial cancer history are important information for assessing the risk of hereditary cancer. We have generated a self-administered questionnaire for patients with gynecologic cancer. This pilot study analyzed the usefulness of this questionnaire and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Kenta, Hirasawa, Akira, Irie-Kunitomi, Haruko, Akahane, Tomoko, Ueki, Arisa, Kobayashi, Yusuke, Yamagami, Wataru, Nomura, Hiroyuki, Kataoka, Fumio, Tominaga, Eiichiro, Banno, Kouji, Susumu, Nobuyuki, Aoki, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421611/ https://www.ncbi.nlm.nih.gov/pubmed/28334914 http://dx.doi.org/10.1093/jjco/hyx019

Ejemplares similares

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer
por: Masuda, Kenta, et al.
Publicado: (2017)

Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)
por: BANNO, KOUJI, et al.
Publicado: (2013)

Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019)

Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015)

Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome
por: BANNO, KOUJI, et al.
Publicado: (2012)

Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells
por: MASUDA, KENTA, et al.
Publicado: (2012)

Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation
por: MASUDA, KENTA, et al.
Publicado: (2012)

Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology
por: Nogami, Yuya, et al.
Publicado: (2019)

Molecular Features and Clinical Management of Hereditary Gynecological Cancers
por: Ueki, Arisa, et al.
Publicado: (2020)

Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016)

New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013)

Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2018)

Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012)

Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
por: Yamagami, Wataru, et al.
Publicado: (2018)

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
por: Akahane, Tomoko, et al.
Publicado: (2022)

Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013)

MicroRNAS in endometrial cancer: recent advances and potential clinical applications
por: Yanokura, Megumi, et al.
Publicado: (2015)

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome
por: Masuda, Kenta, et al.
Publicado: (2011)

LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2019)

Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors
por: Hirasawa, Akira, et al.
Publicado: (2013)

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
por: Masuda, Kenta, et al.
Publicado: (2011)

ARID1A gene mutation in ovarian and endometrial cancers (Review)
por: TAKEDA, TAKASHI, et al.
Publicado: (2016)

Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience
por: Nogami, Yuya, et al.
Publicado: (2020)

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015)

Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer
por: Banno, Kouji, et al.
Publicado: (2014)

GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes
por: Yoshihama, Tomoko, et al.
Publicado: (2018)

Clinical utility of MR spectroscopy for gynecological pelvic abscesses using next-generation sequencing technology for the detection of causative bacteria
por: Nogami, Yuya, et al.
Publicado: (2023)

Recent advances in the molecular mechanisms of Mayer-Rokitansky-Küster-Hauser syndrome
por: Watanabe, Keiko, et al.
Publicado: (2018)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017)

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer
por: Hirasawa, Akira, et al.
Publicado: (2017)

Radiation-induced angiosarcoma of the omentum diagnosed by laparoscopy: A case report
por: Kunitomi, Haruko, et al.
Publicado: (2018)

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013)

New use of microsatellite instability analysis in endometrial cancer
por: Kunitomi, Haruko, et al.
Publicado: (2017)

Polymorphisms of estrogen metabolism-related genes ESR1, UGT2B17, and UGT1A1 are not associated with osteoporosis in surgically menopausal Japanese women
por: Yokota, Megumi, et al.
Publicado: (2015)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2022)

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
por: Nanki, Yoshiko, et al.
Publicado: (2020)

Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia
por: Inoue, Osamu, et al.
Publicado: (2016)

Moderate-Risk Genes for Hereditary Ovarian Cancers Involved in the Homologous Recombination Repair Pathway
por: Abe, Akiko, et al.
Publicado: (2022)

Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells
por: Ueki, Arisa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eph0rfvptbtiv2f2mn6puii3oe